Literature DB >> 24179160

Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer.

Dmitry Lyumkis1, Jean-Philippe Julien, Natalia de Val, Albert Cupo, Clinton S Potter, Per-Johan Klasse, Dennis R Burton, Rogier W Sanders, John P Moore, Bridget Carragher, Ian A Wilson, Andrew B Ward.   

Abstract

The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo-electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24179160      PMCID: PMC3954647          DOI: 10.1126/science.1245627

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

1.  Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04.

Authors:  M Gordon Joyce; Masaru Kanekiyo; Ling Xu; Christian Biertümpfel; Jeffrey C Boyington; Stephanie Moquin; Wei Shi; Xueling Wu; Yongping Yang; Zhi-Yong Yang; Baoshan Zhang; Anqi Zheng; Tongqing Zhou; Jiang Zhu; John R Mascola; Peter D Kwong; Gary J Nabel
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

2.  Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9.

Authors:  Jean-Philippe Julien; Jeong Hyun Lee; Albert Cupo; Charles D Murin; Ronald Derking; Simon Hoffenberg; Michael J Caulfield; C Richter King; Andre J Marozsan; Per Johan Klasse; Rogier W Sanders; John P Moore; Ian A Wilson; Andrew B Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

3.  Rational HIV immunogen design to target specific germline B cell receptors.

Authors:  Joseph Jardine; Jean-Philippe Julien; Sergey Menis; Takayuki Ota; Oleksandr Kalyuzhniy; Andrew McGuire; Devin Sok; Po-Ssu Huang; Skye MacPherson; Meaghan Jones; Travis Nieusma; John Mathison; David Baker; Andrew B Ward; Dennis R Burton; Leonidas Stamatatos; David Nemazee; Ian A Wilson; William R Schief
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

Review 4.  HIV-1 envelope glycoprotein structure.

Authors:  Alan Merk; Sriram Subramaniam
Journal:  Curr Opin Struct Biol       Date:  2013-04-18       Impact factor: 6.809

5.  Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans.

Authors:  Jean-Philippe Julien; Devin Sok; Reza Khayat; Jeong Hyun Lee; Katie J Doores; Laura M Walker; Alejandra Ramos; Devan C Diwanji; Robert Pejchal; Albert Cupo; Umesh Katpally; Rafael S Depetris; Robyn L Stanfield; Ryan McBride; Andre J Marozsan; James C Paulson; Rogier W Sanders; John P Moore; Dennis R Burton; Pascal Poignard; Andrew B Ward; Ian A Wilson
Journal:  PLoS Pathog       Date:  2013-05-02       Impact factor: 6.823

6.  A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization.

Authors:  Wenbo Wang; Jianhui Nie; Courtney Prochnow; Carolyn Truong; Zheng Jia; Suting Wang; Xiaojiang S Chen; Youchun Wang
Journal:  Retrovirology       Date:  2013-02-06       Impact factor: 4.602

7.  Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.

Authors:  Hua-Xin Liao; Rebecca Lynch; Tongqing Zhou; Feng Gao; S Munir Alam; Scott D Boyd; Andrew Z Fire; Krishna M Roskin; Chaim A Schramm; Zhenhai Zhang; Jiang Zhu; Lawrence Shapiro; James C Mullikin; S Gnanakaran; Peter Hraber; Kevin Wiehe; Garnett Kelsoe; Guang Yang; Shi-Mao Xia; David C Montefiori; Robert Parks; Krissey E Lloyd; Richard M Scearce; Kelly A Soderberg; Myron Cohen; Gift Kamanga; Mark K Louder; Lillian M Tran; Yue Chen; Fangping Cai; Sheri Chen; Stephanie Moquin; Xiulian Du; M Gordon Joyce; Sanjay Srivatsan; Baoshan Zhang; Anqi Zheng; George M Shaw; Beatrice H Hahn; Thomas B Kepler; Bette T M Korber; Peter D Kwong; John R Mascola; Barton F Haynes
Journal:  Nature       Date:  2013-04-03       Impact factor: 49.962

8.  Electron counting and beam-induced motion correction enable near-atomic-resolution single-particle cryo-EM.

Authors:  Xueming Li; Paul Mooney; Shawn Zheng; Christopher R Booth; Michael B Braunfeld; Sander Gubbens; David A Agard; Yifan Cheng
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

9.  Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies.

Authors:  Andrew T McGuire; Sam Hoot; Anita M Dreyer; Adriana Lippy; Andrew Stuart; Kristen W Cohen; Joseph Jardine; Sergey Menis; Johannes F Scheid; Anthony P West; William R Schief; Leonidas Stamatatos
Journal:  J Exp Med       Date:  2013-03-25       Impact factor: 14.307

10.  Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120.

Authors:  Leopold Kong; Jeong Hyun Lee; Katie J Doores; Charles D Murin; Jean-Philippe Julien; Ryan McBride; Yan Liu; Andre Marozsan; Albert Cupo; Per-Johan Klasse; Simon Hoffenberg; Michael Caulfield; C Richter King; Yuanzi Hua; Khoa M Le; Reza Khayat; Marc C Deller; Thomas Clayton; Henry Tien; Ten Feizi; Rogier W Sanders; James C Paulson; John P Moore; Robyn L Stanfield; Dennis R Burton; Andrew B Ward; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2013-05-26       Impact factor: 15.369

View more
  446 in total

1.  New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.

Authors:  Nicole A Doria-Rose; Jinal N Bhiman; Ryan S Roark; Chaim A Schramm; Jason Gorman; Gwo-Yu Chuang; Marie Pancera; Evan M Cale; Michael J Ernandes; Mark K Louder; Mangaiarkarasi Asokan; Robert T Bailer; Aliaksandr Druz; Isabella R Fraschilla; Nigel J Garrett; Marissa Jarosinski; Rebecca M Lynch; Krisha McKee; Sijy O'Dell; Amarendra Pegu; Stephen D Schmidt; Ryan P Staupe; Matthew S Sutton; Keyun Wang; Constantinos Kurt Wibmer; Barton F Haynes; Salim Abdool-Karim; Lawrence Shapiro; Peter D Kwong; Penny L Moore; Lynn Morris; John R Mascola
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

2.  Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.

Authors:  Gilad Kaplan; Anna Roitburd-Berman; George K Lewis; Jonathan M Gershoni
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.

Authors:  Devin Sok; Matthias Pauthner; Bryan Briney; Jeong Hyun Lee; Karen L Saye-Francisco; Jessica Hsueh; Alejandra Ramos; Khoa M Le; Meaghan Jones; Joseph G Jardine; Raiza Bastidas; Anita Sarkar; Chi-Hui Liang; Sachin S Shivatare; Chung-Yi Wu; William R Schief; Chi-Huey Wong; Ian A Wilson; Andrew B Ward; Jiang Zhu; Pascal Poignard; Dennis R Burton
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

4.  Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy.

Authors:  Jeong Hyun Lee; Natalia de Val; Dmitry Lyumkis; Andrew B Ward
Journal:  Structure       Date:  2015-09-17       Impact factor: 5.006

Review 5.  HIV broadly neutralizing antibody targets.

Authors:  Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

6.  Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Authors:  Po-Jen Yen; Alon Herschhorn; Hillel Haim; Ignacio Salas; Christopher Gu; Joseph Sodroski; Dana Gabuzda
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

7.  The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling.

Authors:  Shuhei Nakane; Aikichi Iwamoto; Zene Matsuda
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 8.  Strategies to guide the antibody affinity maturation process.

Authors:  Nicole A Doria-Rose; M Gordon Joyce
Journal:  Curr Opin Virol       Date:  2015-04-24       Impact factor: 7.090

9.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Authors:  Ayna Alfadhli; August O Staubus; Philip R Tedbury; Mariia Novikova; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

10.  Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.

Authors:  Rajesh P Ringe; Pavel Pugach; Christopher A Cottrell; Celia C LaBranche; Gemma E Seabright; Thomas J Ketas; Gabriel Ozorowski; Sonu Kumar; Anna Schorcht; Marit J van Gils; Max Crispin; David C Montefiori; Ian A Wilson; Andrew B Ward; Rogier W Sanders; P J Klasse; John P Moore
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.